Jeff Schaffnit: The Power of Community in Rare Blood Disorders
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared a post on LinkedIn:
”This week, I had the privilege of attending the National Bleeding Disorders Foundation (NBDF) Annual Meeting. As always, it’s incredibly inspiring to spend time with the bleeding disorders community and hear directly from the people at the heart of everything we do.
I’m grateful to the patients, caregivers, healthcare professionals, and advocates who shared their perspectives and reminded us why listening matters. Those insights help shape how we think about the future and strengthen our commitment to helping advance research and innovation for the rare blood disorders community.
Thank you to National Bleeding Disorders Foundation for bringing the community together and creating space for these important conversations. I look forward to continuing to work alongside our partners as Sanofi continues to chase the miracles of science for people living with rare blood disorders.”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice